ABSTRACT
In the current study, we investigated the effect of a probiotic bacterium (Lactobacillus rhamnosus ATCC 7469) microencapsulated with alginate and hi-maize starch and coated with chitosan on improving growth factors, body composition, blood chemistry, and the immune response of rainbow trout (initial weight: 18.41 ± 0.32 g). Four experimental diets were formulated to feed fish for 60 days. They were control diet without any additive (C), diet added with beads without probiotic (E), a probiotic sprayed to the diet (L.r), and encapsulated probiotic supplemented diet (E-L.r). The results indicated that feeding with E-Lr significantly improved weight gain (84.98 g) and feed conversion ratio (0.95) compared to the other groups (P < 0.05). Also, fish fed E-Lr diet had a significantly higher value of whole-body protein (17.51%), total protein in the blood (4.98 g/dL), lysozyme (30.66 U/mL), alternative complement pathway hemolytic activity (134 U/mL), superoxide dismutase (203 U/mg protein), and catalase (528.33 U/mg protein) (P < 0.05) as compared to those fed the control diet. Similarly, a higher relative expression of immune-related genes such as interleukin-1 (Il-1) and tumor necrosis factor-alpha (TNF-1α) were reported in those fed E-L.r and L.r diets respectively. Interestingly, the fish fed dietary E-L.r had a significantly lower value of lipid in the whole body (4.82%) and cholesterol in the blood (160.67%) in comparison with those fed the control diet (P < 0.05). At the end of the experiment, all groups were challenged by Yersinia ruckeri where the survival rate of rainbow trout fed dietary E-L.r (70.36%) was statistically higher than that of the others (P < 0.05). Overall, the results suggested that encapsulated probiotic Lact. rhamnosus ATCC 7469 acted better than unencapsulated probiotic and has a potential to improve growth performance, flesh quality, and the immune response of rainbow trout.
Subject(s)
Fish Diseases/therapy , Fish Proteins/genetics , Gene Expression Regulation/drug effects , Lacticaseibacillus rhamnosus/physiology , Oncorhynchus mykiss/immunology , Probiotics/pharmacology , Yersinia Infections/therapy , Alginates/chemistry , Animal Feed/analysis , Animals , Body Composition/drug effects , Catalase/genetics , Catalase/immunology , Cell Encapsulation/methods , Cells, Immobilized , Chitosan/chemistry , Cholesterol/blood , Complement Pathway, Alternative/drug effects , Diet , Disease Resistance/drug effects , Disease Resistance/genetics , Disease Resistance/immunology , Fish Diseases/immunology , Fish Diseases/microbiology , Fish Proteins/immunology , Gene Expression Regulation/immunology , Interleukin-1/genetics , Interleukin-1/immunology , Muramidase/genetics , Muramidase/immunology , Oncorhynchus mykiss/growth & development , Oncorhynchus mykiss/microbiology , Superoxide Dismutase/genetics , Superoxide Dismutase/immunology , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology , Weight Gain/drug effects , Yersinia Infections/immunology , Yersinia Infections/microbiology , Yersinia ruckeri/drug effects , Yersinia ruckeri/growth & development , Yersinia ruckeri/pathogenicityABSTRACT
In this study, the effects of dietary myo-inositol on the skin mucosal immunity and growth of taimen (Hucho taimen) fry were determined. Triplicate groups of 500 fish (initial weight 5.58 ± 0.15 g) were fed different diets containing graded levels of myo-inositol (28.75, 127.83, 343.83, 565.81, and 738.15 mg kg-1) until satiation for 56 days. Thereafter, the nonspecific skin mucus immune parameters, antioxidative capacity, and growth performance were measured. The skin mucus protein and the activities of alkaline phosphatase were significantly higher than those in the control group (P < 0.05). However, there were no significant differences in lysozyme activity among the treatments (P > 0.05). The antimicrobial activity and minimum inhibitory concentration of the skin mucus were increased significantly by myo-inositol supplementation (P < 0.05). The superoxide dismutase, catalase, and glutathione peroxidase activities were significantly elevated in the treatment groups (P < 0.05), whereas the malondialdehyde contents were significantly decreased (P < 0.05). Low-level myo-inositol (28.75 mg kg-1) led to a significantly lower weight gain, feed efficiency, condition factor, and survival rate compared with the other treatments (P < 0.05). In conclusion, dietary myo-inositol deficiency (28.75 mg kg-1) adversely affects the skin mucus immune parameters, antioxidative capacity, and growth performance of Hucho taimen fry.
Subject(s)
Carps/immunology , Dietary Supplements , Immunity, Mucosal/drug effects , Inositol/pharmacology , Mucus/drug effects , Skin/drug effects , Vitamin B Complex/pharmacology , Aeromonas hydrophila/growth & development , Animal Feed , Animals , Carps/genetics , Carps/growth & development , Carps/metabolism , Catalase/immunology , Diet/veterinary , Glutathione Peroxidase/immunology , Mucus/enzymology , Mucus/immunology , Skin/enzymology , Skin/immunology , Superoxide Dismutase/immunology , Yersinia ruckeri/growth & developmentABSTRACT
The present study investigated the possible effects of different anesthetic agents including MS222 (50â¯ppm), 2-Phenoxyethanol (2-PE) (0.2â¯mLâ¯L-1) and clove oil (25â¯ppm), on cutaneous mucosal immune parameters in rainbow trout (Oncorhynchus mykiss). The induction and recovery times for each anesthetic agent were assessed. Also, the immune parameters were measured in skin mucus, 1 and 24â¯h post anesthesia. No significant difference was observed among treatments at 1â¯h post-anesthesia except for bactericidal and alkaline phosphatase (ALP) activities which was significantly enhanced in fish exposed to 2-PE compared to other anesthetics. At 24â¯h post-anesthesia, most of the skin mucosal immune parameters were increased upon exposure to clove oil but decreased following exposure to 2-PE. However, no significant change was noticed after MS222 exposure. These results demonstrated that the anesthetics type should be considered to avoid possible immunosuppression in farmed fish. Furthermore, the present results could be useful for better understanding of alterations in cutaneous mucosal immunity in response to chemical stressors such as anesthetic agents.
Subject(s)
Mucus/immunology , Oncorhynchus mykiss/immunology , Skin/immunology , Alkaline Phosphatase/metabolism , Aminobenzoates/pharmacology , Anesthesia , Anesthetics/pharmacology , Animals , Clove Oil/pharmacology , Esterases/metabolism , Ethylene Glycols/pharmacology , Immunoglobulin G/immunology , Muramidase/immunology , Peptide Hydrolases/metabolism , Skin/enzymology , Yersinia ruckeri/growth & developmentABSTRACT
There is an increasing demand for non-antibiotics solutions to control infectious disease in intensive pig production. Here, one such alternative, namely pig antibodies purified from slaughterhouse blood was investigated in order to elucidate its potential usability to control post-weaning diarrhoea (PWD), which is one of the top indications for antibiotics usage in the pig production. A very cost-efficient and rapid one-step expanded bed adsorption (EBA) chromatography procedure was used to purify pig immunoglobulin G from slaughterhouse pig plasma (more than 100 litres), resulting in >85% pure pig IgG (ppIgG). The ppIgG thus comprised natural pig immunoglobulins and was subsequently shown to contain activity towards four pig-relevant bacterial strains (three different types of Escherichia coli and one type of Salmonella enterica) but not towards a fish pathogen (Yersinia ruckeri), and was demonstrated to inhibit the binding of the four pig relevant bacteria to a pig intestinal cell line (IPEC-J2). Finally it was demonstrated in an in vivo weaning piglet model for intestinal colonization with an E. coli F4+ challenge strain that ppIgG given in the feed significantly reduced shedding of the challenge strain, reduced the proportion of the bacterial family Enterobacteriaceae, increased the proportion of families Enterococcoceae and Streptococcaceae and generally increased ileal microbiota diversity. Conclusively, our data support the idea that natural IgG directly purified from pig plasma and given as a feed supplement can be used in modern swine production as an efficient and cost-effective means for reducing both occurrence of PWD and antibiotics usage and with a potential for the prevention and treatment of other intestinal infectious diseases even if the causative agent might not be known.
Subject(s)
Anti-Bacterial Agents/pharmacology , Diarrhea/veterinary , Dietary Supplements , Escherichia coli Infections/veterinary , Immunoglobulin G/pharmacology , Intestinal Diseases/veterinary , Swine Diseases/prevention & control , Animal Feed , Animals , Animals, Newborn , Anti-Bacterial Agents/blood , Anti-Bacterial Agents/isolation & purification , Bacterial Adhesion/drug effects , Biodiversity , Cell Line , Diarrhea/immunology , Diarrhea/microbiology , Diarrhea/prevention & control , Epithelial Cells/drug effects , Epithelial Cells/immunology , Epithelial Cells/microbiology , Escherichia coli/drug effects , Escherichia coli/growth & development , Escherichia coli Infections/immunology , Escherichia coli Infections/microbiology , Escherichia coli Infections/prevention & control , Immunoglobulin G/blood , Immunoglobulin G/isolation & purification , Intestinal Diseases/immunology , Intestinal Diseases/microbiology , Intestinal Diseases/prevention & control , Intestines/drug effects , Intestines/immunology , Intestines/microbiology , Microbial Sensitivity Tests , Microbiota/drug effects , Salmonella enterica/drug effects , Salmonella enterica/growth & development , Swine , Swine Diseases/immunology , Swine Diseases/microbiology , Weaning , Yersinia ruckeri/growth & developmentABSTRACT
Signature-tagged mutagenesis was used to identify genes essential for survival of Yersinia ruckeri in its natural host, rainbow trout, Oncorhynchus mykiss. A mini-Tn5-Km2 signature-tagged mutant, C6-1, was missing from rainbow trout kidney at 7 days after an immersion challenge. The transposon insertion in C6-1 was in a homologue of the znuA gene of Escherichia coli that encodes ZnuA, a zinc-binding periplasmic protein of the high-affinity zinc transporter ZnuABC. Further sequencing of the C6-1 locus in Y. ruckeri identified homologues of two other genes: znuB, encoding a putative inner membrane permease, and znuC, encoding a putative ATPase. When present on a low-copy plasmid, the znuABC locus of Y. ruckeri fully restored growth of a zinc transport-deficient DeltaznuABC mutant of E. coli. Unlike DeltaznuABC mutants of E. coli and Salmonella typhimurium, the DeltaznuABC mutant of Y. ruckeri did not demonstrate significantly slower growth in zinc-deficient M9 minimal medium or in Luria-Bertani (LB) medium supplemented with the metal chelators EDTA and tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN). In LB medium, the znuA::lacZ and znuCB::lacZ transcriptional fusions of Y. ruckeri were derepressed by addition of EDTA and TPEN and were repressed by addition of zinc and manganese. In a competitive challenge by immersion, the DeltaznuABC mutant was unable to compete with the parental strain and survived poorly in rainbow trout kidney, indicating that the ZnuABC transporter has a role in establishing and maintaining a rainbow trout infection by Y. ruckeri.